
Naveris
Naveris develops highly sensitive blood tests that identify viral cancers significantly earlier than scans or traditional biopsies.
$33.4M Series A ·
Source: fundraisingfox.com
Funding history ↓Acquired by CCareDx on for $160M · HIT Consultant.
Signals
Website registeredAug 30, 2017 (9 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $33.4M | — | fundraisingfox.com |
Timeline
- Acquired by
CCareDx · $160M
Source: HIT Consultant - Website created
Founders and team
- PGPiyush Gupta Executive Chairman, Founder, & Chief Science & Technology Officersource: naveris.com
Companies like Naveris
SSenticellBBearer$4M Seed · Oct 2022
BBiomarx$940K Pre Seed · Jan 2026CCambridge Epigenetix$88M Series B+ · Nov 2021
AallumbraPre Seed · Mar 2026
22Strands BiosciencesPre Seed · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/naveris (get a free API key).